Condition: Urothelial Carcinoma · Sponsor: IRCCS San Raffaele
The project aims to characterize the prognostic role of CTCs in Bladder cancer patients, with the specific aims to better stratify patients with non-muscle invasive bladder cancer at the first transurethral resection of tumor and to identify urothelial biomarker expressed by CTCs.
This description comes directly from the study's public registry record.
Massimo Alfano, PhD · +39022643 · alfano.massimo@hsr.it
Chiara Venegoni, Dr. · +39022643 · venegoni.chiara@hsr.it
Always discuss trial participation with your own doctor first.
| Urology Department | Milan, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06116396